ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0433

In-hospital outcomes of patients admitted due to First-Time Pulmonary Embolism with preexisting Rheumatoid Arthritis: A Nationwide Analysis 2016-2022

John Langley1, Karuna Bista2, Clarisse Yapp2, Nisha Sapkota3, Shukranta Shrestha2 and Sulav Pyakurel1, 1Montefiore New Rochelle Hospital, New Rochelle, NY, 2Montefiore New Rochelle Hospital, New Rochelle, 3Interfaith Medical Center, One Brooklyn Health, Brooklyn, NY

Meeting: ACR Convergence 2025

Keywords: Administrative Data, Mortality, pulmonary, registry, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0430–0469) Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Although it has been documented that patients with Rheumatoid Arthritis may be at increased risk of Pulmonary Embolism, other inpatient outcomes remain largely unexplored. We aimed to better identify the impact of Rheumatoid Arthritis on hospital outcomes in patients admitted for first-time Pulmonary Embolism.

Methods: A retrospective cohort analysis using the U.S. HCUP NIS Database from 2016-2022 was conducted. Patients admitted with a primary diagnosis of a first episode of Pulmonary Embolism with preexisting Rheumatoid Arthritis were identified using ICD-10 codes. The primary outcome was in-hospital mortality. Secondary outcomes were length of stay, resource utilization and need of various interventions. Univariate analysis was done and variables with p < 0.2 were considered for multivariate analysis, adjusting by age, gender, race, Charlson comorbidity index, hospital location and teaching status, size, region and insurance status. Data was considered statistically significant with p-value < 0.05.

Results: From 2016 to 2022, a total of 1,315,394 patients were admitted for a first-time pulmonary embolism (PE). Out of these, 30,474 patients, or 2.32%, had a preexisting diagnosis of rheumatoid arthritis (RA). Notably, these RA patients demonstrated a 35.19% reduction in the odds of mortality (p-value = 0.00). Additionally, they experienced an average decrease in the length of hospital stay by 0.3764 days (p-value = 0.001) and a significant reduction in mean total charges for their hospital stay, amounting to $6,886.12 (p-value = 0.00). Furthermore, RA patients had a 27.87% lower likelihood of undergoing intubation during their hospitalization (p-value = 0.001).

Conclusion: Our research revealed that Rheumatoid Arthritis is associated with improved inpatient outcomes with patients with first-time Pulmonary Embolism. These findings suggest that Rheumatoid Arthritis may confer a protective effect in this population, warranting further investigation.

Supporting image 1Hospitalization Rates of patients admitted for First Time PE with preexisting RA steadily increased from 2016 to 2022.

Supporting image 2The majority of inpatients were White followed by Black and Hispanic individuals.

Supporting image 3Individuals without preexisting RA were hospitalized at earlier ages.


Disclosures: J. Langley: None; K. Bista: None; C. Yapp: None; N. Sapkota: None; S. Shrestha: None; S. Pyakurel: None.

To cite this abstract in AMA style:

Langley J, Bista K, Yapp C, Sapkota N, Shrestha S, Pyakurel S. In-hospital outcomes of patients admitted due to First-Time Pulmonary Embolism with preexisting Rheumatoid Arthritis: A Nationwide Analysis 2016-2022 [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/in-hospital-outcomes-of-patients-admitted-due-to-first-time-pulmonary-embolism-with-preexisting-rheumatoid-arthritis-a-nationwide-analysis-2016-2022/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/in-hospital-outcomes-of-patients-admitted-due-to-first-time-pulmonary-embolism-with-preexisting-rheumatoid-arthritis-a-nationwide-analysis-2016-2022/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology